MedTrace Logo

Retest-reliability and At-home-assessment Feasibility of the 5R-STS

NCT03321357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-07-13

No results posted yet for this study

Summary

The five-repetition sit-to-stand test has been validated and is used primarily in pulmonary medicine and cardiology, and has recently been shown to be a useful tool for the objective assessment of functional impairment in patients with degenerative diseases of the lumbar spine.

The goal of this study is to assess the possibility of supervised and unsupervised at-home-assessment. Validation of at-home-assessment would allow the 5R-STS to be easily used as a follow-up tool in clinical trials, for example.

Conditions

  • Degenerative Disc Disease
  • Spondylolisthesis
  • Spondylosis
  • Herniated Nucleus Pulposus
  • Spinal Stenosis Lumbar
  • Spinal Diseases
  • Spinal Instability

Interventions

DIAGNOSTIC_TEST

five-repetition sit-to-stand test

An armless chair with a hard seat was stabilised by placing it against a wall. Seated participants were asked to come forward on the chair seat until the feet were flat on the floor and to fold their upper limbs across the chest. Participants were then instructed to stand up all the way and sit down once without using the upper limbs. For those unable to complete the initial manoeuvre or who required assistance, the test was terminated. If successful on the initial sit to stand, participants were then asked to stand up all the way and sit down landing firmly, as fast as possible, five times without using the arms. Timing with a stopwatch was started on the command 'go' and stopped at the end of the completed fifth stand; the time taken was recorded as the participant's score. (1) Jones et al.

Sponsors & Collaborators

  • Bergman Clinics

    lead OTHER

Principal Investigators

  • Victor E. Staartjes, MSIII · Department of Neurosurgery, Bergman Clinics, Naarden, The Netherlands

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-08
Primary Completion
2018-06-01
Completion
2018-06-21

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03321357 on ClinicalTrials.gov